KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Stryker (SYK) Capital Expenditures (2016 - 2025)

Stryker (SYK) has disclosed Capital Expenditures for 17 consecutive years, with $268.0 million as the latest value for Q4 2025.

  • Quarterly Capital Expenditures rose 0.75% to $268.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $761.0 million through Dec 2025, up 0.79% year-over-year, with the annual reading at $761.0 million for FY2025, 0.79% up from the prior year.
  • Capital Expenditures for Q4 2025 was $268.0 million at Stryker, up from $187.0 million in the prior quarter.
  • The five-year high for Capital Expenditures was $268.0 million in Q4 2025, with the low at $83.0 million in Q1 2021.
  • Average Capital Expenditures over 5 years is $160.2 million, with a median of $150.0 million recorded in 2023.
  • Peak annual rise in Capital Expenditures hit 88.41% in 2021, while the deepest fall reached 42.36% in 2021.
  • Over 5 years, Capital Expenditures stood at $206.0 million in 2021, then dropped by 8.74% to $188.0 million in 2022, then dropped by 22.87% to $145.0 million in 2023, then skyrocketed by 83.45% to $266.0 million in 2024, then rose by 0.75% to $268.0 million in 2025.
  • According to Business Quant data, Capital Expenditures over the past three periods came in at $268.0 million, $187.0 million, and $183.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.